GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (OTCPK:YPHDF) » Definitions » Future 3-5Y EPS without NRI Growth Rate

YPHDF (Ypsomed Holding AG) Future 3-5Y EPS without NRI Growth Rate : 40.44 (As of Dec. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ypsomed Holding AG Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate is 40.44.


Competitive Comparison of Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate falls into.



Ypsomed Holding AG  (OTCPK:YPHDF) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Ypsomed Holding AG Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.

Ypsomed Holding AG Headlines

From GuruFocus

Half Year 2024 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2023 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2022 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024